Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

TPI-1

Catalog No. T3962Cas No. 79756-69-7
Alias TPI1, TPI 1

TPI-1 is a SHP-1 inhibitor.

TPI-1

TPI-1

Purity: 99.79%
Catalog No. T3962Alias TPI1, TPI 1Cas No. 79756-69-7
TPI-1 is a SHP-1 inhibitor.
Pack SizePriceAvailabilityQuantity
1 mg$48In Stock
2 mg$70In Stock
5 mg$117In Stock
10 mg$198In Stock
25 mg$387In Stock
50 mg$588In Stock
100 mg$838In Stock
500 mg$1,720In Stock
1 mL x 10 mM (in DMSO)$129In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "TPI-1"

Select Batch
Purity:99.79%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
TPI-1 is a SHP-1 inhibitor.
Targets&IC50
SHP1:40 nM.
In vitro
SHP-1 has been identified as a promising target for cancer therapy. TPI-1, starting at an effective concentration of 10 ng/mL, selectively enhances the phosphorylation of SHP-1 substrates (notably pLck-pY394) in Jurkat T cells, without significantly affecting pERK1/2 or pLck-pY505 levels. Moreover, TPI-1 promotes the induction of IFNγ+ cells both in mouse spleen and human peripheral blood[1], demonstrating its potential selectivity and therapeutic efficacy in a cellular context.
In vivo
TPI-1 effectively suppresses the growth of B16 melanoma tumors in mice through a mechanism reliant on T cells when administered orally at tolerable doses, yet it demonstrates minimal impact on B16 cell proliferation in vitro. Additionally, TPI-1 enhances the levels of pLck-pY394 and IFNγ+ cells in mice, further contributing to its anti-tumor activity. Notably, TPI-1 also restricts B16 tumor expansion and extends the survival of mice bearing tumors when given as a subcutaneously tolerated agent[1].
Kinase Assay
Jump-In TI CHO-K cells stably expressing WT or mutant S1P3 are serum-starved for 4 hrs. They are then incubated at 4 °C for 30 min in the binding buffer containing 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 15 mM NaF, 0.5 mM EDTA, 1 mM Na3VO4, 0.5% fatty acid-free bovine serum albumin, and protease inhibitor mixture with 0.1 nM [33P]S1P and increasing concentrations of S1P, SPM-242, or CYM-5541. Cells are washed three times with cold binding buffer. Cell-bound radioactivity is measured by lysing the cells with 0.5% SDS followed by liquid scintillation counting. The raw data is normalized so that the level of [33P]S1P bound to each cell line (WT or mutant) in the absence of competing ligand is referenced as 100% for its own cell line[1].
AliasTPI1, TPI 1
Chemical Properties
Molecular Weight253.08
FormulaC12H6Cl2O2
Cas No.79756-69-7
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (177.81 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.9513 mL19.7566 mL39.5132 mL197.5660 mL
5 mM0.7903 mL3.9513 mL7.9026 mL39.5132 mL
10 mM0.3951 mL1.9757 mL3.9513 mL19.7566 mL
20 mM0.1976 mL0.9878 mL1.9757 mL9.8783 mL
50 mM0.0790 mL0.3951 mL0.7903 mL3.9513 mL
100 mM0.0395 mL0.1976 mL0.3951 mL1.9757 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy TPI-1 | purchase TPI-1 | TPI-1 cost | order TPI-1 | TPI-1 chemical structure | TPI-1 in vivo | TPI-1 in vitro | TPI-1 formula | TPI-1 molecular weight